Sonazoid Enhanced Liver Cancer Trial for Early Detection
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Size of HCC which is detected first
10 years
Yes
Masatoshi Kudo, professor
Principal Investigator
Japan Liver Oncology Group
Japan: Institutional Review Board
JLOG08001
NCT00822991
January 2009
December 2019
Name | Location |
---|